39283715|t|Upregulation of phosphodiesterase 7A leads to the downregulation of cAMP-PKA-CREB-BDNF signaling and neuroinflammation in the hippocampus and contributes to concurrent chronic pain and depression in two mouse models.
39283715|a|BACKGROUND: Phosphodiesterases (PDEs) are enzymes that catalyze the hydrolysis of cyclic adenosine monophosphate AMP (cAMP) and/or cyclic guanosine monophosphate (cGMP). PDE inhibitors can mitigate chronic pain and depression when these disorders occur individually; however, there is limited understanding of their role in concurrent chronic pain and depression. We aimed to evaluate the mechanisms of action of PDE using two mouse models of concurrent chronic pain and depression. METHODS: C57BL/6J mice were subjected to partial sciatic nerve ligation (PSNL) to induce chronic neuropathic pain or injected with complete Freund's adjuvant (CFA) to induce inflammatory pain, and both animals showed depression-like behavior. First, we determined the change in PDE expression in both animal models. Next, we determined the effect of PDE7 inhibitor BRL50481 or hippocampal PDE7A knockdown on PSNL- or CFA-induced chronic pain and depression-like behavior. We also investigated the role of cAMP-protein kinase A (PKA)-cAMP response element binding protein (CREB)-brain-derived neurotrophic factor (BDNF) signaling and neuroinflammation in the effect of PDE7A inhibition on PSNL- or CFA-induced chronic pain and depression-like behavior. RESULTS: This induction of chronic pain and depression in the two animal models upregulated hippocampal PDE7A. Oral administration of PDE7 inhibitor, BRL50481, or hippocampal PDE7A knockdown significantly reduced mechanical hypersensitivity and depression-like behavior. Hippocampal PDE7 inhibition reversed PSNL- or CFA-induced downregulation of cAMP and BDNF and the phosphorylation of PKA, CREB and p65. cAMP agonist forskolin, reversed these changes and caused milder behavioral symptoms of pain and depression. BRL50481 reversed neuroinflammation in the hippocampus in PSNL mice. CONCLUSIONS: Hippocampal PDE7A mediated concurrent chronic pain and depression in both mouse models by inhibiting cAMP-PKA-CREB-BDNF signaling Inhibiting PDE7A or activating cAMP-PKA-CREB-BDNF signaling are potential strategies to treat concurrent chronic pain and depression.
39283715	16	36	phosphodiesterase 7A	Gene	18583
39283715	68	72	cAMP	Chemical	-
39283715	77	81	CREB	Gene	12912
39283715	82	86	BDNF	Gene	12064
39283715	101	118	neuroinflammation	Disease	MESH:D000090862
39283715	168	180	chronic pain	Disease	MESH:D059350
39283715	185	195	depression	Disease	MESH:D003866
39283715	203	208	mouse	Species	10090
39283715	299	333	cyclic adenosine monophosphate AMP	Chemical	-
39283715	335	339	cAMP	Chemical	-
39283715	348	378	cyclic guanosine monophosphate	Chemical	MESH:D006152
39283715	380	384	cGMP	Chemical	MESH:D006152
39283715	415	427	chronic pain	Disease	MESH:D059350
39283715	432	442	depression	Disease	MESH:D003866
39283715	552	564	chronic pain	Disease	MESH:D059350
39283715	569	579	depression	Disease	MESH:D003866
39283715	644	649	mouse	Species	10090
39283715	671	683	chronic pain	Disease	MESH:D059350
39283715	688	698	depression	Disease	MESH:D003866
39283715	709	717	C57BL/6J	CellLine	CVCL:C0MW
39283715	718	722	mice	Species	10090
39283715	797	813	neuropathic pain	Disease	MESH:D009437
39283715	874	891	inflammatory pain	Disease	MESH:D010146
39283715	917	927	depression	Disease	MESH:D003866
39283715	1065	1073	BRL50481	Chemical	MESH:C497936
39283715	1089	1094	PDE7A	Gene	18583
39283715	1129	1141	chronic pain	Disease	MESH:D059350
39283715	1146	1156	depression	Disease	MESH:D003866
39283715	1272	1276	CREB	Gene	12912
39283715	1278	1311	brain-derived neurotrophic factor	Gene	12064
39283715	1313	1317	BDNF	Gene	12064
39283715	1333	1350	neuroinflammation	Disease	MESH:D000090862
39283715	1368	1373	PDE7A	Gene	18583
39283715	1409	1421	chronic pain	Disease	MESH:D059350
39283715	1426	1436	depression	Disease	MESH:D003866
39283715	1479	1491	chronic pain	Disease	MESH:D059350
39283715	1496	1506	depression	Disease	MESH:D003866
39283715	1556	1562	PDE7A.	Gene	18583
39283715	1602	1610	BRL50481	Chemical	MESH:C497936
39283715	1627	1632	PDE7A	Gene	18583
39283715	1676	1692	hypersensitivity	Disease	MESH:D004342
39283715	1697	1707	depression	Disease	MESH:D003866
39283715	1799	1803	cAMP	Chemical	-
39283715	1808	1812	BDNF	Gene	12064
39283715	1845	1849	CREB	Gene	12912
39283715	1854	1857	p65	Gene	19697
39283715	1859	1863	cAMP	Chemical	-
39283715	1872	1881	forskolin	Chemical	MESH:D005576
39283715	1947	1951	pain	Disease	MESH:D010146
39283715	1956	1966	depression	Disease	MESH:D003866
39283715	1968	1976	BRL50481	Chemical	MESH:C497936
39283715	1986	2003	neuroinflammation	Disease	MESH:D000090862
39283715	2031	2035	mice	Species	10090
39283715	2062	2067	PDE7A	Gene	18583
39283715	2088	2100	chronic pain	Disease	MESH:D059350
39283715	2105	2115	depression	Disease	MESH:D003866
39283715	2124	2129	mouse	Species	10090
39283715	2151	2155	cAMP	Chemical	-
39283715	2160	2164	CREB	Gene	12912
39283715	2165	2169	BDNF	Gene	12064
39283715	2191	2196	PDE7A	Gene	18583
39283715	2211	2215	cAMP	Chemical	-
39283715	2220	2224	CREB	Gene	12912
39283715	2225	2229	BDNF	Gene	12064
39283715	2285	2297	chronic pain	Disease	MESH:D059350
39283715	2302	2312	depression	Disease	MESH:D003866
39283715	Negative_Correlation	MESH:C497936	MESH:D000090862
39283715	Negative_Correlation	MESH:C497936	MESH:D004342
39283715	Association	MESH:D003866	12064
39283715	Association	MESH:D000090862	18583
39283715	Negative_Correlation	12912	18583
39283715	Negative_Correlation	MESH:C497936	MESH:D003866
39283715	Negative_Correlation	12064	18583
39283715	Positive_Correlation	MESH:D003866	18583
39283715	Negative_Correlation	MESH:C497936	MESH:D059350
39283715	Positive_Correlation	MESH:D059350	18583
39283715	Negative_Correlation	MESH:D005576	MESH:D010146
39283715	Negative_Correlation	MESH:D005576	MESH:D003866
39283715	Positive_Correlation	MESH:D004342	18583
39283715	Association	MESH:D003866	12912

